Arterial and venous thrombosis due to primary thrombocytosis after splenectomy

---

Copy For Citation

Karaca O. G., Tasar M., Kalender M., Ecevit A. N., Yilmaz M. T.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.22, no.4, pp.830-832, 2014 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 22 Issue: 4
• Publication Date: 2014
• Doi Number: 10.5606/tgkdc.dergisi.2014.9541
• Journal Name: TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
• Page Numbers: pp.830-832
• Keywords: Myeloproliferative disorder, peripheral arterial disease, splenectomy, RISK, ANAGRELIDE
• Ankara University Affiliated: Yes

Abstract

Patients with myeloproliferative disorders such as primary thrombocytosis are prone to vascular thrombotic events. Splenectomy is also a risk factor for thrombocytosis. Such significant thrombosis may cause serious extremity or cardiac problems. It is beneficial to use prophylactic platelet anti-aggregating medication such as aspirin, cytoreductive agents such as hydroxyurea or anticoagulation with close monitoring in these patients that have additional risk factors. In this article, we present a case for whom medical therapy was more important and life-saving than surgery for peripheral vascular thrombosis after splenectomy operation.